Today’s news reports include information on:
Filed under: Drugs in development, Management, Treatment | Tagged: AZD0530, conformal beam, hypofractionated, old, radiotherapy, raduical prostatectomy, standard, young | Leave a comment »
There are several recent reports that address factors specific to the combination of hormone therapy with radiation therapy in the management of prostate cancer, so we thought it would be helpful to offer a topical update. … READ MORE …
Filed under: Management, Treatment | Tagged: adjuvant, androgen deprivation, hormone therapy, neoadjuvant, radiotherapy | 1 Comment »
Today’s news reports deal with items on:
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: arc, bitter melon, focal therapy, hypofractionated, intensity-modulated, radiotherapy, reconstruction, sulforaphane, urinary tract | Leave a comment »
A German group has recently published data from another randomized clinical trial of adjuvant external beam radiotherapy (EBRT) in patients shown to have extraprostatic disease after radical prostatectomy (RP), as compared to a “wait and see” or “watchful waiting” strategy. … READ MORE …
Filed under: Management, Treatment | Tagged: radical prostatectomy, radiotherapy | Leave a comment »
A Canadian group has just added a little more to our knowledge about the role of neoadjuvant hormone therapy in association with radiotherapy after first-line radical prostatectomy (RP). … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: androgen deprivation therapy, neoadjuvant, radiotherapy, salvage | Leave a comment »
In December 2008 we reported the results of the effects of endocrine treatment with or without radiotherapy on mortality, as studied in the SPCG-7/SFUO-3 trial. In patients who received both treatments, prostate cancer-specific mortality was halved, relative to that in patients who received endocrine treatment alone. The same group of researchers have now published data for patient-reported symptoms and quality of life after 4 years in the SPCG-7/SFUO-3 study. … READ MORE …
Filed under: Management, Treatment | Tagged: endocrine therapy, outcome, quality of life, radiotherapy | Leave a comment »
With the exception of a paper on baseline erectile dysfunction in patients undergoing radical prostatectomy, today’s news reports are filled with esoterica that are likely to be of interest only to researchers and the truly obsessed patient! We have provided only very brief summaries of the articles and links to the original abstracts. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Prevention, Treatment, Uncategorized | Tagged: antibody, biopsy, lymph node imaging, radiotherapy | Leave a comment »
Here’s a question that comes up over and over again from newly diagnosed patients: “My doctor is suggesting I get hormones in combination with radiation therapy. How long am I likely to be on hormone therapy?” … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: hormone therapy, neoadjuvant, outcomes, radiotherapy | 2 Comments »
Today being December 31, this will be the final daily news report of the first calendar year of existence for The “New” Prostate Cancer InfoLink.
There are three reports covered in the news below, the most important of which supports the idea that men with diabetes have a reduced risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk, Treatment | Tagged: conformal arc, diabetes, genes, image-guided, radiotherapy | Leave a comment »
In September this year, writing from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Dr. Eyad Abu-Isa addressed breaking news of a Scandinavian trial comparing radiotherapy + hormone therapy to radiotherapy alone in the treatment of locally advanced prostate cancer. The complete results of this study in were just published in The Lancet . … READ MORE …
Filed under: Management, Treatment | Tagged: combination, hormone therapy, radiotherapy | Leave a comment »
There are two news items of significant interest today. One deals with screening behaviors of men living alone; the other with short-term complications following radiotherapy for localized prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: adverse events, radiotherapy, screening | Leave a comment »
A highly respected group of authors has just published a paper that has us beat! … READ MORE …
Filed under: Uncategorized | Tagged: adjuvant, prostatectomy, radiotherapy, survival | 1 Comment »
There are limited data available as yet on the treatment of prostate cancer in HIV-positive men. However, we can expect the need for such treatment to expand over the next 10-15 years. … READ MORE …
Filed under: Uncategorized | Tagged: HIV-positive, radiotherapy | Leave a comment »
There are a bunch of new but distinctly technical reports today that will probably be of limited interest to the majority of readers, but in the interests of knowledge please feel free to … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: brachytherapy, cisplatin, Her2, interleukin-6, motion, nanoparticles, prostate, radiotherapy, TrkA, urethra | Leave a comment »
A team of Australian researchers has reported on the potential use of what they are calling PSA “signatures” as a significant improvement in the way to monitor patients following radiotherapy. … READ MORE …
Filed under: Management | Tagged: prognosis, PSA signature, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 